Tag Archives: C diff patient information

Patient Safety With The Centers for Disease Control and Prevention (CDC) Surveillance Antibiotic Resistance Patient Safety Atlas and More

P A T I E N T   S A F E T Y 

CDC’s Antibiotic Resistance Patient Safety Atlas provides open and interactive data about healthcare-associated infections (HAIs) caused by antibiotic resistant bacteria, which are reported to CDC through the National Healthcare Safety Network (NHSN).

You can customize maps and tables to show antibiotic resistance patterns in Healthcare-Associated Infections (HAI’s)  by filtering the data by geographical area (national, regional, and state), time period, event type, and patient age.

For more information visit the following CDC Website:

http://www.cdc.gov/hai/surveillance/ar-patient-safety-atlas.html

Medicaid Covered Outpatient Drugs Policy– Affordable Care Act

On January 21, 2016 the Centers for Medicare & Medicaid Services (CMS) issued the Covered Outpatient Drugs final rule with comment that addresses key areas of Medicaid drug reimbursement and changes made to the Medicaid Drug Rebate Program by the Affordable Care Act. This final rule also requests additional comments on the definition of line extension, which has a 60 day public comment period which will end on April 1, 2016. View the Fact Sheet to learn how this final rule assists states and the federal government in managing drug costs, establishing the long term framework for implementation of the Medicaid drug rebate program, and creating a more fair reimbursement system for Medicaid programs and pharmacies.

 

For additional information regarding Medicaid Covered Outpatient Drugs Policy

click on the link below:

 

https://www.medicaid.gov/medicaid-chip-program-information/by-topics/benefits/prescription-drugs/covered-outpatient-drugs-policy.html